Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Redmile Group, LLC
Form 13F · Q2 2026

Redmile Group, LLC

CIK 1425738Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.5B
Reported book value
39
Positions
12
Quarters on record
Top 50
Positions

Redmile Group, LLC — holdings

Top 39 positions of 39, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1SRRK Scholar Rock Hldg Corp4.3M−52.5%$237M15.9%
2KRYS Krystal Biotech Inc632,005−6.2%$235M15.8%
3STOK Stoke Therapeutics Inc3.9M−5.2%$129M8.7%
4IMNM Immunome Inc4.9M−11.6%$104M7.0%
5NRIX Nurix Therapeutics Inc4.1M−47.3%$99M6.6%
6ABSI Absci Corporation6.7M−18.3%$78M5.2%
7ANNX Annexon Inc11.9M−18.4%$68M4.6%
8RGNX Regenxbio Inc4.4M+0.0%$52M3.5%
9STTK Shattuck Labs Inc6.9M+24.4%$48M3.2%
10NGNE Neurogene Inc1.4M−3.2%$44M3.0%
11BEAM Beam Therapeutics Inc1.2M−5.9%$40M2.7%
12AGMB Agomab Therapeutics Nv2.7M+1649.7%$35M2.4%
13FATE Fate Therapeutics Inc12.9M+0.0%$35M2.3%
14IDYA Ideaya Biosciences Inc640,202+22.9%$24M1.6%
15SLN Silence Therapeutics Plc2.2M+0.0%$24M1.6%
16COGT Cogent Biosciences Inc503,321−26.8%$19M1.3%
17SLDB Solid Biosciences Inc1.9M−3.1%$19M1.3%
18NUVB Nuvation Bio Inc3.0M−3.9%$17M1.2%
19CLDX Celldex Therapeutics Inc New433,921+65.9%$16M1.1%
20CLYM Climb Bio Inc1.2M—$16M1.1%
21ALXO Alx Oncology Hldgs Inc7.4M−7.2%$15M1.0%
22BMRN Biomarin Pharmaceutical Inc265,169+52.5%$15M1.0%
23XENE Xenon Pharmaceuticals Inc229,374−12.7%$14M0.9%
24ZYME Zymeworks Inc491,654+0.0%$13M0.9%
25ADCT Adc Therapeutics Sa11.5M−25.5%$12M0.8%
26AURA Aura Biosciences Inc1.7M—$12M0.8%
27ODTX Odyssey Therapeutics Inc425,000—$8M0.5%
28LIVN Livanova Plc93,154−14.0%$8M0.5%
29ESTA Establishment Labs Hldgs Inc88,964−14.0%$8M0.5%
30CBLL Ceribell Inc386,786+0.0%$8M0.5%
31DBVT Dbv Technologies S A410,440−16.5%$7M0.5%
32INSM Insmed Inc51,234—$5M0.4%
33PRME Prime Medicine Inc1.4M−12.6%$5M0.3%
34ATRA Atara Biotherapeutics Inc441,701+0.0%$5M0.3%
35EPRX Eupraxia Pharmaceuticals Inc611,400−12.7%$4M0.3%
36ORIC Oric Pharmaceuticals Inc362,010−12.9%$4M0.3%
37ARDX Ardelyx Inc641,750−12.5%$3M0.2%
38IVVD Invivyd Inc2.6M−1.9%$2M0.2%
39PLRX Pliant Therapeutics Inc772,126+0.0%$880,2240.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.